2010 PdCCRS: Whole Brain Priority-driven following local Collaborative Cancer University of treatment of intracranial Cancer $650,111.00 01/03/2011 60 Sydney, NSW 2006 Australia Sydney metastases of melanoma - a Research randomised phase III trial. Scheme App1009485 2010 PdCCRS: A randomised, placebo-controlled trial of Priority-driven concurrent cediranib Collaborative [AZD2171] with platinum - Cancer University of Cancer based chemotherapy & $270,597.80 01/03/2011 24 Sydney, NSW 2006 Australia Sydney Research maintenance cediranib in Scheme women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602 Priority-driven Collaborative 2010 PdCCRS: Tumour protein Cancer University of Cancer D52 over-expression and DNA $48,132.40 01/03/2011 12 Sydney, NSW 2006 Australia Sydney Research repair in cancer. App1007020 Scheme 2010 PdCCRS: START Phase III Priority-driven Study of Active Surveillance Collaborative Therapy Against Radical Cancer University of Cancer Treatment in Patients $329,320.20 01/03/2011 38 Sydney, NSW 2006 Australia Sydney Research Diagnosed with Favourable Scheme Risk Prostate Cancer. App1004932 2010 PdCCRS: Meeting the Priority-driven education and support needs Collaborative Cancer Curtin University of of women with breast cancer Cancer $220,993.30 01/03/2011 59 Perth, WA 6845 Australia Technology who are referred for Research radiotherapy: A multiple - Scheme baseline study. App1006458 Priority-driven 2010 PdCCRS: A novel Collaborative approach to predict Cancer University of Cancer metastatic potential of $650,905.20 01/03/2011 36 Adelaide, SA 5005 Australia Adelaide Research prostate cancer at diagnosis. Scheme App1012337 Priority-driven 2010 PdCCRS: The impact of Cancer Collaborative University of aberrant progesterone $48,129.40 01/03/2011 12 Sydney, NSW 2006 Australia Cancer Sydney signalling on lineage Research specification during early
Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney 2010 PdCCRS: Whole Brain following local treatment of intracranial metastases of melanoma - a randomised phase III trial. App1009485 $650,111.00 01/03/2011 60 Sydney, NSW 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney 2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602 $270,597.80 01/03/2011 24 Sydney, NSW 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney 2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer. App1007020 $48,132.40 01/03/2011 12 Sydney, NSW 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney 2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer. App1004932 $329,320.20 01/03/2011 38 Sydney, NSW 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Curtin University of Technology 2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study. App1006458 $220,993.30 01/03/2011 59 Perth, WA 6845 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Adelaide 2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis. App1012337 $650,905.20 01/03/2011 36 Adelaide, SA 5005 Cancer Australia Priority-driven Collaborative Cancer Research University of Sydney 2010 PdCCRS: The impact of aberrant progesterone signalling on lineage specification during early $48,129.40 01/03/2011 12 Sydney, NSW 2006
grants_reporting_20170703_3.docx